Verano Holdings (VRNO) Total Current Liabilities (2021 - 2026)
Verano Holdings (VRNO) reported Total Current Liabilities of $118.9 million for Q1 2026, down 29.07% year-over-year from $167.6 million in Q1 2025, and down 15.22% quarter-over-quarter from $140.3 million in Q4 2025.
Verano Holdings (VRNO) Total Current Liabilities (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Total Current Liabilities data on file, last reported at $118.9 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $118.9 million, down 29.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $118.9 million (down 29.07% YoY), and the FY2025 annual result was $140.3 million, down 30.94% from the prior year.
- Total Current Liabilities retreated to $118.9 million in Q1 2026 per VRNO's latest filing, from $140.3 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $586.8 million in Q2 2022 and troughed at $118.9 million in Q1 2026.
- A 5-year average of $310.4 million and a median of $356.4 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities grew 23.58% in 2024, then plunged 67.06% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $386.6 million in 2022, then increased by 6.61% to $412.2 million in 2023, then tumbled by 50.72% to $203.1 million in 2024, then sank by 30.94% to $140.3 million in 2025, then retreated by 15.22% to $118.9 million in 2026.
- Business Quant data shows VRNO's Total Current Liabilities at $118.9 million in Q1 2026, $140.3 million in Q4 2025, and $143.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn | 118.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.91 Mn |
| Dec 31, 2025 | 140.26 Mn |
| Sep 30, 2025 | 143.41 Mn |
| Jun 30, 2025 | 147.83 Mn |
| Mar 31, 2025 | 167.64 Mn |
| Dec 31, 2024 | 203.11 Mn |
| Sep 30, 2024 | 435.38 Mn |
| Jun 30, 2024 | 360.59 Mn |
| Mar 31, 2024 | 414.98 Mn |
| Dec 31, 2023 | 412.19 Mn |
| Sep 30, 2023 | 352.30 Mn |
| Jun 30, 2023 | 348.32 Mn |
| Mar 31, 2023 | 363.39 Mn |
| Dec 31, 2022 | 386.65 Mn |
| Sep 30, 2022 | 384.20 Mn |
| Jun 30, 2022 | 586.78 Mn |
| Dec 31, 2021 | 470.52 Mn |